Related Experiment Video
Updated: Oct 25, 2025

Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS
Published on: July 11, 2016
Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired
Liying Sun1,2, Chi Zhang1,2, Shuhua An3
1NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Abstract:
The objective of this study was to evaluate the value of molecular methods in the management of community-acquired pneumonia (CAP) in children. Previously developed mass spectrometry (MS)-based methods combined with quantitative real-time PCR (combined-MS methods) were used to describe the aetiology and evaluate antibiotic therapy in the enrolled children. Sputum collected from 302 children hospitalized with CAP were analyzed using the combined-MS methods, which can detect 19 viruses and 12 bacteria related to CAP. Based on the results, appropriate antibiotics were determined using national guidelines and compared with the initial empirical therapies. Respiratory pathogens were identified in 84.4% of the patients (255/302). Co-infection was the predominant infection pattern (51.7%, 156/302) and was primarily a bacterial-viral mixed infection (36.8%, 111/302). Compared with that using culture-based methods, the identification rate for bacteria using the combined-MS methods (61.8%, 126/204) increased by 28.5% (p <0.001). Based on the results of the combined-MS methods, the initial antibiotic treatment of 235 patients was not optimal, which mostly required switching to β-lactam/β-lactamase inhibitor combinations or reducing unnecessary macrolide treatments. Moreover, using the combined-MS methods to guide antibiotic therapy showed potential to decrease the length of stay in children with severe CAP. For children with CAP, quantitative molecular testing on sputum can serve as an important complement to traditional culture methods. Early aetiology elucidated using molecular testing can help guide the antibiotic therapy.
Insights
Molecular methods improve diagnosis of community-acquired pneumonia (CAP) in children by identifying pathogens and guiding antibiotic therapy. This approach enhances bacterial detection and optimizes treatment, potentially reducing hospital stays.
Area of Science:
- Pediatric infectious diseases
- Molecular diagnostics
- Microbiology
Background:
- Community-acquired pneumonia (CAP) is a significant cause of childhood illness.
- Accurate etiological diagnosis is crucial for effective antibiotic management.
- Traditional culture-based methods have limitations in pathogen detection.
Purpose of the Study:
- To evaluate the utility of combined mass spectrometry (MS)-based and quantitative real-time PCR (combined-MS) methods for diagnosing pediatric CAP.
- To assess the impact of molecular diagnostics on guiding antibiotic therapy.
- To compare the diagnostic yield of molecular methods with traditional culture techniques.
Main Methods:
- Sputum samples from 302 hospitalized children with CAP were analyzed using combined-MS methods.
- The methods detected 19 viruses and 12 bacteria associated with CAP.
- Etiological findings guided antibiotic selection, compared to initial empirical treatments.
Main Results:
- Respiratory pathogens were identified in 84.4% of patients.
- Co-infections, particularly bacterial-viral, were prevalent (51.7%).
- Combined-MS methods increased bacterial identification by 28.5% compared to culture (61.8% vs. 33.3%).
Conclusions:
- Quantitative molecular testing of sputum is a valuable adjunct to culture methods for pediatric CAP.
- Early etiological diagnosis via molecular methods aids in optimizing antibiotic selection.
- Guiding therapy with molecular results may reduce unnecessary antibiotic use and shorten hospital stays for severe CAP.
More Related Videos
Related Concept Videos
Pneumonia III: Complications and Assessment
MALDI-TOF Mass Spectrometry
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Methods of Classification and Identification

